Catumaxomab for Treatment of Peritoneal Carcinomatosis in Patients With Gastric Adenocarcinomas

Clinical trial NCT01504256 · COMPLETED

Trial details

NCT number: NCT01504256
Sponsor: AIO-Studien-gGmbH
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Gastric Adenocarcinoma With Peritoneal Carcinomatosis Siewert Type II Adenocarcinoma of Esophagogastric Junction With Peritoneal Carcinomatosis Siewert Type III Adenocarcinoma of Esophagogastric Junction With Peritoneal Carcinomatosis

Start date: 2011-10-01
Primary completion: 2017-03-01
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.